UN Integrated Regional Information NetworkImportant note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Click here to return to UN Integrated Regional Information Network main menu
DonateNow




Africa: Thinking outside the AIDS funding box

Integrated Regional Information Networks - October 15, 2009


NAIROBI, 15 October 2009 (PlusNews) - As traditional sources of financial aid dry up, new and innovative approaches to fundraising may be the best hope of generating money for HIV/AIDS efforts.

Fundraiser UNITAID has collected an estimated US$1.2 billion since 2006 for the treatment of HIV, tuberculosis and malaria, mainly from a small levy on airline tickets bought in 34 participating countries, most of them in Africa.

"With the current financial crisis it is going to be very difficult to achieve the MDGs [UN Millennium Development Goals] through official government aid, so innovative methods of financing the fight against these diseases must be sought," said Philippe Douste-Blazy, chair of UNITAID and a UN special advisor on innovative development financing at the first UNITAID implementers' meeting in the Kenyan capital, Nairobi, on 15 October.

A World Bank report in April projected that the global economic downturn could put the treatment of more than 1.7 million people in the developing world at risk by the end of 2009 through drug shortages, treatment interruptions and higher burdens of AIDS-related diseases.

According to Douste-Blazy, the airline levy gives participating developing nations an opportunity to contribute to treatment in their countries rather than depending on handouts from the developed world. "The idea is for funding not to move only from the North to the South, but also from the South to the South," he said.

Beth Mugo, Kenya's Minister for Public Health and Sanitation, told delegates it was time African governments played a bigger role in health financing. "We need long-term financing for health, and we must put pressure on our leaders to implement their Abuja pledge [made at an African Union Summit in the capital of Nigeria in 2001] to dedicate 15 percent of the budget to health," she said. "Few are doing so - in Kenya for example, only seven percent of our national budget is spent on health."

Cote d'Ivoire, Niger, Madagascar and Mauritius are applying the airline levy, while Benin, Burkina Faso and Kenya have said they will introduce it. The levy ranges from US$1 to $2 on economy-class tickets, and up to $40 on business- and first-class fares.

The funds are channelled through NGOs like the Clinton HIV/AIDS Initiative (CHAI), which has used the money to put 170,000 children in 38 countries on antiretroviral drugs (ARVs).

From 2010 individuals will be able to make a voluntary contribution of as little as US$2 when purchasing air tickets, booking hotel rooms or renting cars as part of a new initiative being launched by UNITAID in partership with the Millennium Foundation for Innovative Finance for Health, formed by the UN in 2008.

Strengthening African health systems

The meeting in Nairobi will discuss other ways in which UNITAID and its partner countries can finance the scale-up of HIV, tuberculosis and malaria treatment, but participants also stressed the urgent need for Africa's public health systems to become more efficient.

"In this part of the world we have weak public health systems; we have problems diagnosing these diseases, and when we do diagnose them we have difficulty finding qualified staff to treat patients," said David Okello, Kenya country representative for the UN World Health Organisation (WHO).

There were also calls for greater efficiency in the approval and distribution of essential drugs across the continent. "When providing more drugs, we need to make sure that systems exist to ensure they reach the patients," Okello pointed out.

The UNIADS country coordinator for Kenya, Erasmus Morah, argued that a single medicines agency for Africa would improve the efficiency of drug evaluation and supervision.

"This would replace the fragmented system that currently exists, put an end to manufacturers running from country to country to seek product approval, and reduce the time patients must wait for new drugs."


091015
IR091016


Copyright © 2009 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980 – 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .